What is COGT's current stock price?

As of now, COGT is trading at $34.32, with a daily change of +3.16%.

Market Overview Trending Stocks Stock Screener Trade Insights

Top Rated Stocks Most Active Stocks Top Potential Stocks Top Momentum Stocks Leaderboard

About Us Log In Sign Up Plans & Pricing Contact Us Terms of Use Privacy Policy

Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist

COGT Stock Analysis & IQ Rating | Cogent Biosciences I

COGT SYMBOL Badge

Cogent Biosciences I

$34.32

+$0.49 | +3.16%

Create Alerts

Overview

Comments

Insights

Risks

Rating

Chart

Analysts

Street

Sentiment

Headlines

52W High

$ 36.29

MKT CAP

$ 4.89B

52W Low

$ 3.72

VOL

$ 2.63M

P/E Ratio

N/A

AVG VOL

$ 3.72M

RSI

TREND

COGT Stock IQ

Login to see Cogent Biosciences I (COGT) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid

COGT Target Price

Login to display

Strengths

COGT Rewards

Upgraded on attractively valued

COGT Rewards

Outperform the market

Technical Indicators

COGT Technical Indicators

5+ Days Up

Chart

$16.35 (+109.91%)

$11.77 (+191.59%)

$7.07 (+385.43%)

$9.58 (+258.25%)

1year

6month

3month

1month

COGT Risk Level

COGT has Low risk level based on volatility, sector strength, volume, investor confidence, and outlook.

Click here to check what is your level of risk

Low

LOW

HIGH

COGT Analysts Opinion

COGT overall standing based on key factors, offering insights into analysts perspectives and market expectations.
menu Hover over the category for more information

COGT Analysts Opinion

COGT Analysts opinion is positive and also has improved from the past 3 months

COGT Street Sentiment

Analysts perspectives on the stock desirability, trend direction, and growth potential.

76%

Buy
Opinion

Trend
Score

Potential
Score

Consensus Rating

50%

75%

83%

COGT Street Sentiment

COGT Street Sentiment is extremely bullish and have positive views on the near-term outlook

COGT Performance Sentiment

Sentiments overview associated with COGT events and the stock performance.

76%

15%

Positive

Negative

25 out of 33
events present

5 out of 33
events present

Very Bullish

Bullish

Neutral

Bearish

Very Bearish

Technical Price Levels

Average key support and resistance price levels.

Login to display

Support
Price

$35.26

Resistance
Price

$14.13

Current Price Range

$35.26

Show methods +

Linked to COGT

IQ

Close Price

Change

PFE

3.89

25.08

-2.77%

NVS

3.71

130.89

-0.82%

COGT Latest Analysis +

HC Wainwright & Co. Maintains Cogent Biosciences (COGT) Buy Recommendation. Fintel reports that on November 13 2025 HC Wainwright &. Co. maintained coverage of Cogent Biosciences (NasdaqGS:COGT) with a Buy recommendation. Analyst Price Forecast Suggests 33.65% Downside

Today

$34.32 | +3.16%

Momentum

Rating

Cogent Biosciences prices equity offering and 1.625% convertible senior notes.

Wed Nov 12, 2025

$35.26 | +5.51%

Activity

Cogent Biosciences Announces Pricing of Concurrent Public Offerings of Common Stock and 1.625% Convertible Senior Notes Due 2031. WALTHAM Mass. and BOULDER Colo. Nov. 11 2025 (GLOBE NEWSWIRE) -- Cogent Biosciences Inc. (Cogent) (NASDAQ:) a biotechnology company focused on developing precision therapies for genetically defined diseases today announced the pricing of its previously announced underwritten public offering of 9677420 shares of its common stock at a public offering price of $31.00 per

Wed Nov 12, 2025

$35.26 | +5.51%

Activity

Baird Maintains Cogent Biosciences (COGT) Neutral Recommendation. Fintel reports that on November 11 2025 Baird maintained coverage of Cogent Biosciences (NasdaqGS:COGT) with a Neutral recommendation. Analyst Price Forecast Suggests 32.85% Downside

Wed Nov 12, 2025

$35.26 | +5.51%

Momentum

Potential

Rating

Leerink Partners Maintains Cogent Biosciences (COGT) Outperform Recommendation. Fintel reports that on November 10 2025 Leerink Partners maintained coverage of Cogent Biosciences (NasdaqGS:COGT) with a Outperform recommendation. Analyst Price Forecast Suggests 30.87% Downside

Tue Nov 11, 2025

$33.42 | +2.96%

Momentum

Potential

Rating

Cogent Biosciences (COGT) Climbs to New Record High on Cancer Treatment Drug Trial. We recently published 10 Stocks Beating the Market with Eye-Popping Gains. Cogent Biosciences Inc. (NASDAQ:COGT) is one of the best-performing stocks on Monday. Cogent Biosciences soared to a new seven-year high on Monday as investors cheered promising results of the last clinical trial phase that tested the efficacy of its drug candidate for a type [….]

Tue Nov 11, 2025

$33.42 | +2.96%

Activity

Momentum

Potential

Cogent Biosciences: Soaring On Blowout GIST Data - I Expect More Upside.

Tue Nov 11, 2025

$33.42 | +2.96%

Momentum

Potential

COGT Crosses Above Average Analyst Target. In recent trading shares of Cogent Biosciences Inc (Symbol: COGT) have crossed above the average analyst 12-month target price of $22.92 changing hands for $32.46/share. When a stock reaches the target an analyst has set the analyst logically has two ways to react: downgrade

Tue Nov 11, 2025

$33.42 | +2.96%

Potential

Rating

Cogent Biosciences Inc. (COGT) Discusses Positive Phase 3 PEAK Trial Results of Bezuclastinib in Gastrointestinal Stromal Tumors - Slideshow.

Mon Nov 10, 2025

$32.46 | +119.03%

Activity

Cogent Biosciences Inc. (COGT) Discusses Positive Phase 3 PEAK Trial Results of Bezuclastinib in Gastrointestinal Stromal Tumors Transcript.

Mon Nov 10, 2025

$32.46 | +119.03%

Activity

FAQ About COGT Stock Insights

What is COGT current stock price?

What are COGT stock strengths?

What risks are associated with COGT stock?

When is COGT next earnings report?

What is COGT market cap and volume?

What is COGT's current Stock IQ?

Should I buy COGT stock right now?

Is COGT a Strong Buy right now?

What does a 'Strong Buy' rating mean for COGT?

What does a 'Strong Sell' rating mean for COGT?

What factors influence COGT's Stock IQ?

Explore our COGT Stock insights

In-Depth Market Analysis and Trends
Expert Insights on Market Dynamics
Tailored COGT Stock Strategies
Effective Risk Management

FIND US ON

Receive our COGT Daily Alerts

Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts

Market Trends

Stay ahead of the market

Market trends

Investment tips

Market analysis service

Investment Insights

Future potential

Informed investment decisions

Investment analysis

IInvestment strategies

Stock Analysis

In-depth stock analysis

Performance analysis

Stock market insights

Financial trends analysis

COGT COGT Badge

Cogent Biosciences I

Current Price

$34.32

+$0.49 | +3.16%

52W High

$ 36.29

MKT CAP

$ 4.89B

52W Low

$ 3.72

VOL

$ 2.63M

P/E Ratio

N/A

AVG VOL

$ 3.72M

RSI

TREND

Create Alerts

Overview

Comments

Insights

Risks

Rating

Chart

Analysts

Street

Sentiment

Target Price

Login to display

Not Enough Information

Stock Insights

Strengths

COGT Rewards

Upgraded on attractively valued

COGT Rewards

Outperform the market

Technical Indicators

COGT Technical Indicators

5+ Days Up

Linked to COGT

Symbol

IQ

Close

Change

PFE

3.89

25.08

-2.77%

NVS

3.71

130.89

-0.82%

COGT Stock IQ

Login to unlock Cogent Biosciences I (COGT) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid

Chart

$16.35 (+109.91%)

$11.77 (+191.59%)

$7.07 (+385.43%)

$9.58 (+258.25%)

1year

6month

3month

1month

COGT Analysts Opinion

COGT Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
menu Hover over the category for more information

COGT Analysts Opinion

COGT Analysts opinion is positive and also has improved from the past 3 months

COGT Street Sentiment

Analysts perspectives on the stock desirability, trend direction, and growth potential.

76%

Buy
Opinion

Trend
Score

Potential
Score

Consensus Rating

50%

75%

83%

COGT Street Sentiment

COGT Street Sentiment is extremely bullish and have positive views on the near-term outlook

COGT Risk Level

COGT has Low risk level based on volatility, sector strength, volume, investor confidence, and outlook.

Click here to check what is your level of risk

Low

LOW

HIGH

COGT Performance Sentiment

Sentiments overview associated with COGT events and the stock performance.

76%

15%

Positive

Negative

25 out of 33
events present

5 out of 33
events present

Very Bullish

Bullish

Neutral

Bearish

Very Bearish

Technical Price Levels

Average key support and resistance price levels.

Login to display

Support
Price

$35.26

Resistance
Price

$14.13

Current Price Range

$35.26

Show methods +

COGT Latest Analysis

HC Wainwright & Co. Maintains Cogent Biosciences (COGT) Buy Recommendation. Fintel reports that on November 13 2025 HC Wainwright &. Co. maintained coverage of Cogent Biosciences (NasdaqGS:COGT) with a Buy recommendation. Analyst Price Forecast Suggests 33.65% Downside

Today

$34.32 | +3.16%

Momentum

Rating

Cogent Biosciences prices equity offering and 1.625% convertible senior notes.

Wed Nov 12, 2025

$35.26 | +5.51%

Activity

Cogent Biosciences Announces Pricing of Concurrent Public Offerings of Common Stock and 1.625% Convertible Senior Notes Due 2031. WALTHAM Mass. and BOULDER Colo. Nov. 11 2025 (GLOBE NEWSWIRE) -- Cogent Biosciences Inc. (Cogent) (NASDAQ:) a biotechnology company focused on developing precision therapies for genetically defined diseases today announced the pricing of its previously announced underwritten public offering of 9677420 shares of its common stock at a public offering price of $31.00 per

Wed Nov 12, 2025

$35.26 | +5.51%

Activity

Baird Maintains Cogent Biosciences (COGT) Neutral Recommendation. Fintel reports that on November 11 2025 Baird maintained coverage of Cogent Biosciences (NasdaqGS:COGT) with a Neutral recommendation. Analyst Price Forecast Suggests 32.85% Downside

Wed Nov 12, 2025

$35.26 | +5.51%

Momentum

Potential

Rating

Leerink Partners Maintains Cogent Biosciences (COGT) Outperform Recommendation. Fintel reports that on November 10 2025 Leerink Partners maintained coverage of Cogent Biosciences (NasdaqGS:COGT) with a Outperform recommendation. Analyst Price Forecast Suggests 30.87% Downside

Tue Nov 11, 2025

$33.42 | +2.96%

Momentum

Potential

Rating

Cogent Biosciences (COGT) Climbs to New Record High on Cancer Treatment Drug Trial. We recently published 10 Stocks Beating the Market with Eye-Popping Gains. Cogent Biosciences Inc. (NASDAQ:COGT) is one of the best-performing stocks on Monday. Cogent Biosciences soared to a new seven-year high on Monday as investors cheered promising results of the last clinical trial phase that tested the efficacy of its drug candidate for a type [….]

Tue Nov 11, 2025

$33.42 | +2.96%

Activity

Momentum

Potential

Cogent Biosciences: Soaring On Blowout GIST Data - I Expect More Upside.

Tue Nov 11, 2025

$33.42 | +2.96%

Momentum

Potential

COGT Crosses Above Average Analyst Target. In recent trading shares of Cogent Biosciences Inc (Symbol: COGT) have crossed above the average analyst 12-month target price of $22.92 changing hands for $32.46/share. When a stock reaches the target an analyst has set the analyst logically has two ways to react: downgrade

Tue Nov 11, 2025

$33.42 | +2.96%

Potential

Rating

Cogent Biosciences Inc. (COGT) Discusses Positive Phase 3 PEAK Trial Results of Bezuclastinib in Gastrointestinal Stromal Tumors - Slideshow.

Mon Nov 10, 2025

$32.46 | +119.03%

Activity

Cogent Biosciences Inc. (COGT) Discusses Positive Phase 3 PEAK Trial Results of Bezuclastinib in Gastrointestinal Stromal Tumors Transcript.

Mon Nov 10, 2025

$32.46 | +119.03%

Activity

Discover COGT Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends, and the future potential of COGT. We're here to help you make informed investment decisions today.

FIND US ON

Receive our COGT Daily Alerts

Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts

Market trends

In-depth stock analysis

Informed investment decisions

Stock market insights

Stock trading tips

Stock analysis

COGT Stock trends

COGT Stock performance

COGT Stock analysis

COGT investment strategies

Stock strategies

Trading strategies

StocksRunner updates

StocksRunner Insights

Financial Reports

Disclaimer: Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor. The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses. Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.

Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").

This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.

✕

Don't Be a Sheep, Be a StocksRunner

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

Sign up for free and

continue analysing COGT

Signup to Stocksrunner

Already a Member? Click here to Login

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence, and cutting-edge intelligence.

✕

Don't Be a Sheep, Be a StocksRunner

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

Sign up for free and

continue analysing COGT

Signup to Stocksrunner

Already a Member? Click here to Login

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence, and cutting-edge intelligence.

COGT Stock Analysis & IQ Rating | Cogent Biosciences I

COGT Stock IQ

COGT Target Price

COGT Risk Level

COGT Analysts Opinion

COGT Street Sentiment

COGT Performance Sentiment

Technical Price Levels

Explore our COGT Stock insights

Receive our COGT Daily Alerts

COGT Stock IQ

COGT Street Sentiment

COGT Risk Level

Technical Price Levels

Discover COGT Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends, and the future potential of COGT. We're here to help you make informed investment decisions today.

Receive our COGT Daily Alerts

COGT Runner Alarm